Barclays reaffirmed their overweight rating on shares of Microsoft (NASDAQ:MSFT) in a research report sent to investors on Friday morning. Barclays currently has a $117.00 target price on the software giant’s stock, up from their previous target price of $108.00.
Things are moving fast in renewable energy. Really fast. Consider that in 2008 wind farms supplied just 1.5% of all electricity in the United States. But by 2019 wind power is expected to contribute 6.9% of American electricity and overtake hydropower as the top renewable energy source.
The rise of wind power wouldn’t have been possible without two companies in particular, which combine....More>>>
The average 30-year mortgage rate rose by 2 basis points to 3.96% on Monday, which equates to a $475.11 monthly payment per $100,000 borrowed. (A basis point equals one hundredth of a percentage point.) A month ago, the equivalent payment was higher by $1.73.
The average 15-year mortgage rate fell 3 basis points to 3.12%, equating to a $696.37 monthly payment per $100,000 borrowed. A month....More>>>
Oil prices hit a 10-year low in January 2016, but since then they rose 47%. That means the top oil stocks of 2016 saw huge returns.
To give investors an overview of how well oil stocks did in 2016, Money Morning made a list of thetop oil stocks of 2016. To make our list of the top oil stocks, we looked at companies with biggest stock price growth and market cap of at least $1 billion.
Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies,....More>>>
With the holiday season around the corner,consumers are busy searching for the products to buy while investors are busy searching for the companies whose products consumers are buying. Just a couple of week back GoPro (NSDQ:GPRO) was one such company on which investors were willing to bet as its products were likely to fly off the shelves of retail outlets. But then the things changed. While GoPro’s....More>>>
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its regulatory pathway for its Fabry Disease treatment. After the company had several collaborative discussions with the U.S. Food and Drug Administration (FDA), Amicus plans to collect additional data on gastrointestinal (GI) symptoms in Fabry patients who have an amenable mutation.
Ingevity (NYSE:NGVT) had its price target increased by Loop Capital to $89.00 in a research note published on Wednesday. The brokerage currently has a $90.05 rating on the stock. The analysts noted that the move was a valuation call.
A number of other analysts have also weighed in on the
BP, (BP) gets a lot of interest from investors, and has a lot of articles written about it. Many of these articles feature the generous dividend the company pays, upon which many retirees rely for income. Other articles feature the depressed stock price relative to its cohort group,
The S&P 500 Consumer Staples Index has tanked 6% over the past month amid mixed first-quarter earnings from the group's biggest names. For some on Wall Street, Coca-Cola's (KO) report card disappointed in the area of pricing power both in the U.S. and Eur